Lockheed Martin has licensed the bionic augmentation technology Dermoskeleton™ from B-Temia Inc, in order to progress its research and product development for industrial and military exoskeletons. The licence will allow Lockheed Martin to pursue the technology for military, industrial, commercial and first-responder applications. The Dermoskeleton will give increased mobility and load-carrying capacity ...